Company News
Humacyte Shares Drop 6% After Offering Announcement
Humacyte Inc announced an underwritten public offering of common stock, with all shares being sold by the company.
Underwriters have a 30‑day option to buy up to 15% of the shares, with Barclays, BTIG
